Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Pluristem Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility 

 

January 30, 2013 - (Pluristem) - "Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has taken possession of and is moving into its new state-of-the-art GMP facility. The facility allows for the production of mass quantities of PLacental eXpanded (PLX) cells that possess the advantages of being grown utilizing Pluristem's patented 3D bioreactor technology." Read Full Press Release

 

Posted on 4-Feb-13 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: